Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 13 Lung Neoplasms 12 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 7 Carcinoma, Renal Cell 6 Urinary Bladder Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neuroblastoma 4 Glioblastoma 4 Colorectal Neoplasms 4 Brain Neoplasms 4 Small Cell Lung Carcinoma 3 Oropharyngeal Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Mouth Neoplasms 3 Melanoma 3 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Ganglioneuroblastoma 3 Disease 3 Carcinoma, Hepatocellular 3 Carcinoma 3 Ureteral Neoplasms 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Medulloblastoma 2 Lymphoma, Mantle-Cell 2

Interventions

Tamoxifen 6 Radiotherapy 3 Anastrozole 3 Medroxyprogesterone 2 Letrozole 2 Chemotherapy, Adjuvant 2 pembrolizumab 1 oxybutynin 1 exemestane 1 Watchful Waiting 1 Specimen Handling 1 Risedronic Acid 1 Radiation 1 Psychiatric Rehabilitation 1 Observation 1 Norethindrone Acetate 1 Mometasone Furoate 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Laser Therapy 1 Fentanyl 1 Estrogens, Conjugated (USP) 1 Estradiol 1 Early Intervention, Educational 1 Counseling 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Carcinoma In Situ × Magnetic Resonance Spectroscopy × Clear all

NCT06671912 2026-06-02

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡